The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts - from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases.
Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.
If you enjoy the podcast, please leave us a rating and review!
For more news visit www.vjhemonc.com
Harnessing the power of immunotherapy in myeloma and amyloidosis
The myeloma treatment landscape has seen a lot of progress in the last few years, with several novel therapies emerging,...
The impact of AI and machine learning algorithms in MDS
Artificial intelligence (AI) and machine learning algorithms are transforming treatment and prognosis in hematological malignancies, as well as other areas...
MMRF-CoMMpass: the genomic basis of myeloma subtypes
Despite significant advances in molecular profiling and treatments for multiple myeloma, patients with high-risk and ultra high-risk disease still have...
Genomics in the age of immuno-oncology
Immunotherapies are at the forefront of myeloma treatment and there are many questions remaining. Defining high-risk is important when making...
Understanding multiple myeloma at the single-cell level
Relapsed/refractory (R/R) multiple myeloma remains an incurable hematological malignancy with an unmet clinical need. It is necessary to gain a...
Recent advances in amyloidosis treatment
Amyloidosis is a disease that results from the accumulation of a toxic, insoluble protein called amyloid in various tissues and...